Cepheid Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,972

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $91.8M

  • Investors
  • 4

Cepheid General Information

Description

Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. The company's technology offers rapid on-demand genetic, sexual health, SARS-CoV-2, virology, oncology and critical infectious disease testing options, thereby helping laboratories and hospitals in making faster clinical decisions as opposed to culture or batch-based PCR testing.

Contact Information

Website
www.cepheid.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Parent Company
Corporate Office
  • 904 Caribbean Drive
  • Sunnyvale, CA 94089
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cepheid Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 22-Oct-2021 $91.8M Completed Generating Revenue
8. Grant 22-Mar-2020 00.00 Completed Generating Revenue
7. Grant 31-Dec-2017 00.00 Completed Generating Revenue
6. Merger/Acquisition 04-Nov-2016 000 000.00 000 Completed Generating Revenue
5. Grant 13-Nov-2014 00.00 000.00 Completed Generating Revenue
4. IPO 21-Jun-2000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 06-Mar-2000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 30-Nov-1998 $8.2M Completed Generating Revenue
1. Early Stage VC (Series B) 01-Apr-1998 $8.2M $8.2M Completed Generating Revenue
To view Cepheid’s complete valuation and funding history, request access »

Cepheid Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. The company
Diagnostic Equipment
Sunnyvale, CA
4,972 As of 2022
000.00
0000000000

0-0000

onsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000 000000000
Uppsala, Sweden
000 As of 0000
00000
00000000 00000

000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000 000000000
Menlo Park, CA
00 As of 0000
00000
00000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cepheid Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Q-linea Formerly VC-backed Uppsala, Sweden 000 00000 00000000 00000
Ionpath Venture Capital-Backed Menlo Park, CA 00 00000 00000000000 00000
Quanterix Formerly PE-Backed Billerica, MA 000 00000 00000000 00000
StageZero Life Sciences Corporation Richmond Hill, Canada 00 0000 000000000 0000
Revvity Corporation Waltham, MA 00000 00.000 000000000 00.000
You’re viewing 5 of 16 competitors. Get the full list »

Cepheid Patents

Cepheid Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240166411-A1 Film seal assembly and single lid assay cartridge and associated methods Pending 28-Sep-2022 000000000
US-20240177288-A1 Transfer learning methods and models facilitating defect detection Pending 01-Sep-2022 0000000000
US-20240175847-A1 Seal failure detection system and methods Pending 01-Sep-2022 000000000
US-20240173713-A1 Faulty unit detection system and methods Pending 01-Sep-2022 000000000
US-D1026244-S1 Diagnostic assay system Active 12-Aug-2022 0
To view Cepheid’s complete patent history, request access »

Cepheid Executive Team (16)

Name Title Board Seat Contact Info
John Bishop Chairman & Chief Executive Officer
David Persing Ph.D Executive Vice President & Chief Medical and Technology Officer
Jonathan Siegrist Chief Technology Officer
Thomas Gutshall Co-Founder & Chairman
Joseph Smith Senior Vice President & General Counsel
You’re viewing 5 of 16 executive team members. Get the full list »

Cepheid Board Members (8)

Name Representing Role Since
John Bishop Cepheid Chairman & Chief Executive Officer 000 0000
Thomas Gutshall Cepheid Co-Founder & Chairman 000 0000
You’re viewing 2 of 8 board members. Get the full list »

Cepheid Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cepheid Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advanced Technology Ventures Venture Capital Minority 000 0000 000000 0
Band of Angels Angel Group Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
CampVentures Venture Capital Minority 000 0000 000000 0
Innogenetics Corporation Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Cepheid Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OncoMark 01-Mar-2021 0000000000 Diagnostic Equipment
Laboratory Supply (customer relationship ) 01-Oct-2014 000000000 0000 Buildings and Property 0000 0000
Stretton Scientific 03-Nov-2008 0000000000 00.000 Diagnostic Equipment
Sangtec Molecular Diagnostics 14-Feb-2007 0000000000 0000 Diagnostic Equipment 0000 0000
Actigenics 09-Aug-2006 Merger/Acquisition 00.000 Biotechnology
To view Cepheid’s complete investments and acquisitions history, request access »

Cepheid Subsidiaries (2)

Company Name Industry Location Founded
OncoMark Diagnostic Equipment Dublin, Ireland 2007
Stretton Scientific Diagnostic Equipment Stretton, United Kingdom 0000
To view Cepheid’s complete subsidiaries history, request access »

Cepheid FAQs

  • When was Cepheid founded?

    Cepheid was founded in 1996.

  • Who is the founder of Cepheid?

    Thomas Gutshall is the founder of Cepheid.

  • Who is the CEO of Cepheid?

    John Bishop is the CEO of Cepheid.

  • Where is Cepheid headquartered?

    Cepheid is headquartered in Sunnyvale, CA.

  • What is the size of Cepheid?

    Cepheid has 4,972 total employees.

  • What industry is Cepheid in?

    Cepheid’s primary industry is Diagnostic Equipment.

  • Is Cepheid a private or public company?

    Cepheid is a Private company.

  • What is Cepheid’s current revenue?

    The current revenue for Cepheid is 00000.

  • How much funding has Cepheid raised over time?

    Cepheid has raised $27.3M.

  • Who are Cepheid’s investors?

    Advanced Technology Ventures, Band of Angels, Bill & Melinda Gates Foundation, CampVentures, and Innogenetics are 5 of 13 investors who have invested in Cepheid.

  • Who are Cepheid’s competitors?

    Q-linea, Ionpath, Quanterix, StageZero Life Sciences, and Revvity are some of the 16 competitors of Cepheid.

  • When was Cepheid acquired?

    Cepheid was acquired on 22-Oct-2021.

  • Who acquired Cepheid?

    Cepheid was acquired by Danaher.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »